Speculation Rampant In Leadup To WHO Director General Election Today 23/05/2017 by William New, Intellectual Property Watch Leave a Comment Speculation in the hallways of United Nations headquarters in Geneva was rampant in the days and hours leading up to this afternoon’s election of a new director general to lead the UN World Health Organization, but solid information about who will win was hard to come by. The outcome after a series votes is expected sometime tonight. Update! According to sources, the first round of voting is over. Results: Tedros 95, Nabarro 52, Nishtar 38. Second round update! Tedros 121, Nabarro 62. Third round underway.
Chan’s Last Speech To WHA Opening: Affordable Medicines, Innovation, Listen To Civil Society, Partner With Industry 22/05/2017 by Catherine Saez, Intellectual Property Watch 1 Comment In her final opening speech to the annual World Health Assembly, Director General Margaret Chan today underlined progress made and left to make, and highlighted access to medicines as the most contentious issue of her decade of service. She stressed the importance of innovation, and investment in health, acknowledged the necessity of partners such as the private sector and civil society, and encouraged scientific evidence in decision making. And she focussed strongly on global security and health emergencies.
World Health Assembly 70: A Spectator’s Guide To Program/Budget, Election, Polio Transition 22/05/2017 by Mara Pillinger for Intellectual Property Watch Leave a Comment The 70th annual World Health Assembly (WHA), now underway in Geneva, is shaping up to be one of the most consequential in memory. With a record-setting nine-day, 76-item agenda, plus dozens of official and unofficial side events, delegates and WHO followers alike will be hard-pressed to keep up. But yesterday’s introductory briefing, hosted by the Global Health Centre at the Graduate Institute, provided an overview of the proceedings and a few pointers on where to look first. Four items, in particular, stand out.
Slew Of Side Events At World Health Assembly: Focus On Health Security, SDGs 22/05/2017 by Elise De Geyter for Intellectual Property Watch Leave a Comment The 70th annual World Health Assembly kicked off today with the focus of thousands on the grand plenary hall in United Nations headquarters in Geneva. But in the surrounding rooms and buildings in and outside of the UN, a wide array of side events is taking place. IP-Watch’s Global Health Policy News took a look at a selection of these events and found this year a stronger focus has emerged on the subject of health security and the new UN Sustainable Development Goals (SDGs). These are occurring alongside the usual disease-specific events and those on various sectors of humanity, the focus on access to medical products, and a variety of other current topics.
Taiwan Lobbies For Invitation To World Health Assembly, China Firmly Bars The Way 22/05/2017 by Catherine Saez, Intellectual Property Watch 3 Comments Taiwan will not be allowed to participate in the World Health Assembly (WHA) this year as an observer, the WHA has decided on its opening day. Some hours earlier today, Taiwan’s minister of health gave a press conference to denounce the fact that the country has not been invited by the World Health Organization, and saying that Taiwan needs the WHO, and the WHO needs Taiwan.
No Free Lunch, G20 Health Ministers Find At First Meeting 20/05/2017 by Monika Ermert for Intellectual Property Watch 3 Comments Group of 20 health ministers today finished their first joint table top exercise to simulate the outbreak of a new deadly viral pandemic in “Anycountry” and passed a seven-page final resolution on pandemic preparedness and antimicrobial resistance. Non-governmental experts and health organizations welcomed the first ever meeting of health ministers in the G20 format, but see a risk of framing the debate from a global North security perspective. And despite a call of urgency with regard to antimicrobial resistance, the G20 could not agree to include the de-linking of the cost of investment in R&D from the price of medical products.
Draft Cancer Resolution Might Be Set For Approval At World Health Assembly 19/05/2017 by Catherine Saez, Intellectual Property Watch 1 Comment According to sources, countries have agreed in the nick of time on a draft resolution on cancer prevention, control, and access to cancer medicines, and in particular the price of new cancer medicines, to be examined at the World Health Assembly next week.
Attacks On WHO Candidate Are Defamatory, ‘Colonial’, Ambassador Says 17/05/2017 by Catherine Saez, Intellectual Property Watch 1 Comment The African Union delegation to the United Nations came in outspoken numbers to a press briefing today to express unshakable support for the Ethiopian candidate to be the next head of the World Health Organization, Tedros Adhanom Ghebreyesus.
IFPMA Priorities At WHA: Election, Antibiotics, Cancer, Pandemics 17/05/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment The new head of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has hit the ground running in Geneva, and is weighing in on a variety of policy issues, this week providing a list of priorities for the research-based pharma industry at the upcoming annual World Health Assembly.
World Health Assembly Topic: Pandemic Flu Financing, Virus Sharing, Extension 17/05/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment There are many who see the World Health Organization mechanism to prepare and face the next influenza pandemic and insure availability of treatments as a success. However, some questions remain.